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Activating protein-1 (AP-1) binding TPA responsive elements (TRE) are located downstream of the transcription initiation
site in the U5 region of the HIV-1 long terminal repeat (LTR). These downstream sequence elements, termed DSE, can bind
both AP-1 and CREB/ATF transcription factors. Recently, we demonstrated that the DSE are also cAMP-responsive elements
(CRE), since they mediated activation signals elicited by cholera toxin (Ctx), a potent activator of the cAMP-dependent
protein kinase A (PKA) signal transduction pathway. In the present study, we demonstrate that the HIV-1 DSE can mediate
the transcriptional synergy elicited by the combination of Ctx and TNFa. Ctx combined with TNFa or IL-1b to produce a
synergistic increase in p24 antigen production in U1 promonocytic cells. Transfection studies of LTR reporter constructs
indicated that mutation of the DSE sites abrogated the LTR-mediated synergy induced by Ctx and TNFa, whereas the
synergy induced by Ctx and IL-1b was unaffected, suggesting TNFa and IL-1b cooperate differently with the cAMP/PKA
activation pathway to induce HIV-1 expression in U1 cells. Because the DSE are also TRE sites, we assessed the effect of
the agonist combinations on AP-1-dependent transcription. TNFa as well as IL-1b cooperated with Ctx to produce a
synergistic activation of AP-1-mediated transcription. These data indicate that the TRE-like cAMP-responsive DSE sites
within the 5*-untranslated leader can mediate the transcriptional cooperativity between TNFa and the cAMP/PKA pathway.
Since the DSE and TRE sites cannot bind CREB/ATF homodimers, we propose a mechanism in which the HIV-1 DSE bind
heterodimers composed of both AP-1 and CREB/ATF proteins. q 1997 Academic Press
INTRODUCTION may be critical cellular factors for HIV-1 expression and
replication. HIV-1 infection activates the cAMP/PKA path-
Activation of HIV-1 transcription is mediated by host
way in T-cell lines and primary peripheral blood lympho-
cell transcription factors binding to cis-regulatory ele-
cytes (Nokta and Pollard, 1991, 1992). We recently
ments in the viral long terminal repeat (LTR) (Gaynor,
showed that HIV-1 infection increases the nuclear con-
1992). Proinflammatory cytokines such as TNFa and IL-
tent and binding activity of CREB (Rabbi et al., 1997).
1b induce HIV-1 LTR transcription by activating NF-kB
Moreover, in chronically infected U1 monocytic cells,
(Granowitz et al., 1995). Additionally, HIV-1 replication is
cholera toxin (Ctx), a potent activator of the cAMP/PKA
a cAMP-dependent event and elevated levels of cAMP
signaling pathway, increases intracellular levels of cAMP
is associated with HIV-1 replication (Nokta and Pollard,
(Chowdhury et al., 1993) and CREB binding activity (Rabbi
1991; Hofmann et al., 1993). cAMP is an important second
et al., 1997). Ctx can also synergize with TNFa to in-
messenger in the cAMP-dependent protein kinase A crease HIV-1 replication through the stimulation of viral
(PKA) signaling pathway that leads to the activation of mRNA expression (Chowdhury et al., 1993). However, the
transcription factors of the CREB/ATF family (Lee and transcriptional basis for the synergy between Ctx and
Masson, 1993). CREB/ATF are nuclear phosphoproteins TNFa has not been determined, nor have the critical cis-
that belong to the class of basic leucine zipper (bZip) regulatory LTR elements been identified.
transcription factors. CREB/ATF can combine with AP-1 We recently showed that Ctx activates HIV-1 transcrip-
(i.e., Jun and Fos proteins) through their leucine zipper tion in U1 cells through TRE-like cAMP-responsive down-
domains to form functional heterodimers that recognize stream sequence elements (DSE) located at /95 and
TRE (TPA responsive element) and CRE (cAMP-respon- /160 (relative to the transcription initiation site) (Rabbi
sive element) sites in the promoter regions of cellular et al., 1997). The HIV-1 DSE bind both AP-1 and CREB/
and viral genes (Karin, 1995; Ziff, 1990; Montminy and ATF proteins in nuclear cell extracts (Rabbi et al., 1997;
Bilezikjian, 1987; Hai and Curran, 1991; Chatton et al., Roebuck et al., 1993, 1996), suggesting the DSE may
1994; Benbrook and Jones, 1990; De Cesare et al., 1995). integrate multiple signal transduction pathways to facili-
PKA and transcription factors of the CREB/ATF family tate the activation of HIV-1 gene expression. Therefore,
we sought to determine whether the DSE could mediate
activation signals elicited by Ctx and the proinflammatory1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (312) 942-2808. E-mail: kroebuck@rush.edu. cytokines TNFa and IL-1b. We demonstrate herein that
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ATF (Roebuck et al., 1997). The 0120 DSst LTR CAT
construct was derived from the 0120 LTR CAT plasmid.
It was generated by digestion with SstI, removing the
183-bp fragment between /39 and /222, and recircu-
larizing with T4 ligase. The 0109 LTR LUC construct
was obtained from Dr. Calame (Columbia University of
Physicians and Surgeons, NY) and contains both NF-
kB binding sites and downstream sequences to /80
(Henderson et al., 1996).
Cell culture, transient transfections, and reporter
gene assays
The human promonocytic U1 cell line was obtained
from the NIH AIDS Research and Reference Reagent
Program (Bethesda, MD) and grown in RPMI 1640 me-
dium supplemented with 10% fetal calf serum. The U1
cells were treated with Ctx, TNFa, or IL-1b as indicated
in the figure legends and assayed 72 hr later for p24
antigen production in the medium by ELISA (AIDS Vac-
cine Program, Fredrick, MD). U1 cells were transfected
with the constructs shown in Fig. 1 by the DEAE dextran
method as previously described (Finnegan et al., 1996).FIG. 1. Plasmid constructs used in the transfection studies. The full-
Chloramphenicol acetyltransferase (CAT) [Enzyme Cata-length LTR CAT construct contains LTR sequences from 0453 to /232
linked to the CAT reporter gene. The 0120 LTR CAT construct contains loge No. (EC) 2.3.1.28] and firefly luciferase (EC 1.13.12.7)
LTR sequences from0120 to/232. The0120 DSst LTR CAT construct activity assays were performed as described before
contains a deletion of 5*-untranslated sequences between /39 and (Roebuck et al., 1993)./222. The 0109 LTR LUC construct contains LTR sequences from
0109 to /80. The 091 LTR CAT construct contains LTR sequences
from 091 to /232. The 091 M6 LTR CAT construct is identical to the RESULTS
091 LTR CAT construct except for point mutations in the /95 and
Cholera toxin cooperates with TNFa and IL-1b to/160 DSE, which introduce NotI and BssHII restriction sites, respec-
tively. The TRE PL LUC construct contains four tandem AP-1 binding activate HIV-1 transcription
sites upstream of the rat prolactin TATA box. The NF-kB, Sp1, and DSE
sites are indicated by solid rectangles. The transcription initiation site Ctx has been shown to increase intracellular levels of
(/1) is indicated by the arrow. The 5*-untranslated sequences are cAMP in U1 cells (14) and activate HIV-1 expression in
shown in gray. synergy with TNFa (Chowdhury et al., 1993). As shown
in Fig. 2, Ctx cooperated with TNFa as well as IL-1b to
produce a clearly synergistic increase in HIV-1 p24 anti-the transcriptional synergy elicited by the combination of
gen production in U1 cells. Because U1 cells containCtx and TNFa is mediated by the TRE-like DSE sites.
latent HIV-1 provirus, these data suggest that the cAMP/
PKA signaling pathway stimulated by Ctx cooperates
MATERIALS AND METHODS with the signaling pathways activated by the proinflam-
matory cytokines TNFa and IL-1b to synergistically acti-Plasmids and LTR CAT constructs
vate HIV-1 proviral transcription.
To determine whether these activation signals cooper-The LTR structures of the plasmids used in these stud-
ies are shown in Fig. 1. The HIV-1 LTR CAT, 0120 LTR ated to activate HIV-1 LTR transcription, the full-length
wild-type HIV-1 LTR CAT construct shown in Fig. 1 wasCAT, 091//232 LTR CAT, 091//232 M6 LTR CAT, and
TRE PL LUC reporter plasmids were described pre- cotransfected into U1 cells together with or without a Tat
expressing plasmid and assessed for its ability to medi-viously (Rabbi et al., 1997; Roebuck et al., 1993, 1996).
The HIV-1 LTR CAT construct contains a full-length LTR ate Ctx and cytokine activation signals. Tat is a potent
transactivator of HIV-1 transcription. It transactivates thefrom0453 to/232. The091//232 M6 LTR CAT is identi-
cal to 091//232 LTR CAT with the exception of the point HIV-1 LTR by binding to the trans-activating response
(TAR) RNA element present at the 5* end of viral tran-mutations in the DSE located at nucleotide positions/95
and /160. The TRE PL LUC construct contains the pro- scripts. U1 cells have been reported to express subopti-
mal levels of Tat, since cotransfection of a Tat expressinglactin TATA box linked to four AP-1 binding sites (TGA-
GTCAG). The TRE PL LUC is an AP-1-dependent reporter plasmid stimulates LTR activity (Cannon et al., 1994). As
shown in Fig. 3, Ctx, TNFa, and IL-1b each markedlygene since it is transactivated by AP-1 but not CREB/
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to overcome the inhibitory effects of the NRE, perhaps
because it can stimulate the rate of transcription initiation
(Laspia et al., 1989).
5*-Untranslated leader region is required to mediate
the cooperativity between cholera toxin and cytokine
We previously showed that Ctx acts primarily through
the TRE-like DSE sites in the 5*-untranslated leader re-
gion, whereas TNFa acts primarily through the NF-kB
binding sites (Rabbi et al., 1997). To determine whether
downstream LTR sequences were required to mediate
the cooperativity between Ctx and cytokine, the 0120
DSst LTR CAT construct, which contains a deletion of
the DSE in the 5*-untranslated leader region (Fig. 1) was
transfected into U1 cells. As shown in Fig. 4, this deletion
abrogated the cooperativity between Ctx and the cyto-
kines. These data indicate that LTR sequences in the 5*-
untranslated leader containing the DSE are required for
the agonist cooperativity.
Since this deletion also removed part of the TAR ele-
ment rendering it unresponsive to Tat transactivation and
because Tat may play a role in the agonist cooperativity,
FIG. 2. Cholera toxin cooperates with TNFa and IL-1b to produce a we also assessed the ability of a similar contruct, lacking
synergistic increase in HIV-1 expression. U1 cells were treated for 72
hr with TNFa, IL-1b, and cholera toxin (Ctx), either separately or in
combination. HIV-1 expression was assessed by measuring p24 core
antigen in the supernatants by ELISA. The data represent the mean fold
increase over untreated control cells { the standard error of triplicate
experiments.
stimulated LTR-directed CAT activity. Ctx in combination
with each cytokine further enhanced CAT activity. How-
ever, this Ctx-induced enhancement was approximately
additive in the absence of the Tat expressing plasmid.
In contrast, in the presence of Tat, Ctx cooperated with
both TNFa and IL-1b to produce a clearly synergistic
increase in LTR-directed transcription. Tat also en-
hanced the TNFa response, which is consistent with
results demonstrating that Tat can potentiate TNFa-in-
duced HIV-1 expression (Westendorp et al., 1995). Taken
together, these data demonstrate that Ctx can act in con-
cert with TNFa and IL-1b to stimulate Tat-mediated
transactivation of the HIV-1 LTR.
To determine if the negative regulatory element (NRE)
of the HIV-1 LTR had an effect on the agonist cooperativ-
ity, U1 cells were transfected with an LTR construct con-
taining a deletion of LTR sequences to nucleotide posi-
tion 0120, which removes the negative control se-
FIG. 3. Cholera toxin cooperates with TNFa and IL-1b in the pres-
quences upstream of the kB enhancer (Fig. 1). As shown ence of Tat to produce a synergistic increase in HIV-1 LTR activity. U1
in Fig. 4, the0120 LTR CAT construct mediated a greater cells were transfected with the full-length LTR CAT construct with (solid
bars) or without (open bars) the Tat expressing plasmid and treatedagonist response than the full-length LTR. In addition,
for 24 hr with cholera toxin (Ctx), TNFa, and IL-1b either individuallythis construct mediated the cooperativity between Ctx
or in combination. CAT activity was determined as described under
and the cytokines even in the absence of exogenous Materials and Methods. The data represent the mean fold increase
Tat, indicating that Tat transactivation is not essential for over untreated control cells { the standard error of at least three
experiments.agonist cooperativity. Tat, however, appears to be critical
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FIG. 4. Cholera toxin cooperates with TNFa and IL-1b in the absence of Tat when the NRE is deleted but not when the 5*-untranslated leader
region is deleted. U1 cells were transfected with the 0120 LTR CAT or the 0120 DSst LTR CAT construct and treated for 24 hr with cholera toxin
(Ctx), TNFa, and IL-1b, either individually or in combination. The data represent the mean fold increase over untreated control cells { the standard
error of at least three experiments.
the DSE but containing a functional TAR element, to me- greater than additive effect between Ctx and IL-1b, but
not between Ctx and TNFa. These data indicate that thediate the cooperativity between Ctx and the cytokines. As
shown in Fig. 5, the 0109 LTR LUC construct mediated a cooperativity between Ctx and the two cytokines differs.
The cooperativity between Ctx and IL-1b requires se-
quences containing the TAR element, whereas the coop-
erativity between Ctx and TNFa requires additional 5*-
untranslated sequences downstream of TAR.
TRE-like downstream sequence elements mediate the
cooperativity between cholera toxin and TNFa
To determine if the HIV-1 DSE are required for agonist
cooperativity, we compared the ability of the 091 LTR CAT
and its mutant DSE derivative091 M6 LTR CAT, to respond
to Ctx and cytokine. These LTR constructs contain a single
NF-kB binding site and are identical except for mutations
that inactivate the DSE sites (see Fig. 1). As shown in
Fig. 6, Ctx cooperated with TNFa and IL-1b to produce a
synergistic increase in LTR activity. Transfection of the091
M6 LTR CAT construct showed that mutations in the DSE
abrogate the cooperativity between Ctx and TNFa, but not
the cooperativity between Ctx and IL-1b consistent with
the results from the 0109 LTR LUC construct. In contrast,
to the TNFa response, which was not affected by mutation
of the DSE, the IL-1b response was stimulated. Collectively,
these data indicate that TNFa and IL-1b cooperate differ-
ently with the cAMP/PKA signaling pathway, suggesting
the cytokines activate LTR transcription by distinct mecha-
nisms. The cooperativity between Ctx and TNFa require
the DSE, whereas the cooperativity between Ctx and IL-1b
is independent of the DSE.
FIG. 5. IL-1b cooperativity with cholera toxin is independent of DSE. AP-1 binding sites mediate the cooperativity between
U1 cells were transfected with the0109 LTR LUC construct and treated cholera toxin and TNFa or IL-1b
for 24 hr with cholera toxin (Ctx), TNFa, and IL-1b, either individually
Because the HIV-1 DSE are AP-1 binding sites, weor in combination. The data represent the mean fold increase over
untreated control cell { the standard error of three to six experiments. determined whether Ctx could cooperate with the cyto-
AID VY 8798 / 6a4f$$$663 10-02-97 10:51:35 vira AP: VY
426 RABBI, AL-HARTHI, AND ROEBUCK
FIG. 6. TNFa cooperativity with cholera toxin is dependent on DSE. U1 cells were transfected with either the 091 LTR WT CAT construct (solid
bars) or the 091 LTR M6 CAT construct (open bars) and treated for 24 hr with cholera toxin (Ctx), TNFa, and IL-1b, either individually or in
combination. The data represent the mean fold increase over untreated control cells { the standard error of at least three experiments.
kines to mediate AP-1-dependent transcription in the ab-
sence of any HIV-1 LTR sequences. A heterologous mini-
mal promoter (TRE PL LUC) containing multiple AP-1
binding sites similar to the HIV-1 DSE was transfected
into U1 cells and its ability to mediate the Ctx and cyto-
kine responses was assessed. We showed previously
that this luciferase construct is transactivated by AP-1-
expressing plasmids (Roebuck et al., 1997), including
JunD and cFos, which can bind the HIV-1 DSE (Roebuck
et al., 1996). We also showed that this sequence could
bind CREB/ATF proteins in cells, but not purified CREB/
ATF proteins, a binding pattern that was identical to the
HIV-1 DSE (Rabbi et al., 1997), indicating that the DSE
and TRE can bind similar sets of AP-1/CREB/ATF tran-
scription factors. As shown in Fig. 7, TNFa and IL-1b
both cooperated with Ctx to produce a clearly synergistic
increase in luciferase activity, even though individually
they did not appreciably stimulate this construct. The
cooperativity between Ctx and the cytokines was medi-
ated by the AP-1 sites, since the parental construct lack-
ing them was not responsive to Ctx, nor able to mediate
synergy with the cytokines (data not shown). These data
indicate that AP-1 binding sites can mediate the coopera-
tivity between Ctx and TNFa as well as IL-1b indepen-
dent of any HIV-1 sequences.
FIG. 7. Cholera toxin cooperates with TNFa and IL-1b through AP-
DISCUSSION 1 binding sites. U1 cells were transfected with the TRE PL LUC con-
struct and treated for 24 hr with cholera toxin (Ctx), TNFa, and IL-1b,
HIV-1 expression is modulated by the intracellular lev- either individually or in combination. The data represent the mean fold
els of cAMP, suggesting the cAMP/PKA signal transduc- increase over untreated control cells { the standard error of triplicate
experiments.tion pathway and the transcription factors of the CREB/
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ATF family play a regulatory role in viral expression. Re- ability to bind CREB. CREB is a substrate for PKA and
the PKA phosphoacceptor site of CREB is required forcently, we showed that activation of the cAMP/PKA path-
way can increase HIV-1 LTR activity through TRE-like transcriptional activation (Gonzalez et al., 1991). Consen-
sus AP-1 binding sites such as the collagenase TRE sitecAMP-responsive downstream sequence elements
(termed DSE) that bind both AP-1 and CREB/ATF proteins can also bind CREB/ATF proteins (Rabbi et al., 1997). In
contrast, purified CREB/ATF were unable to bind the TRE(Rabbi et al., 1997). In this study, we investigated the
mechanism by which the cAMP/PKA pathway cooperates and DSE sites (Rabbi et al., 1997), indicating CREB/ATF
proteins possibly form heterodimers with AP-1 proteinswith the pathways induced by the proinflammatory cyto-
kines TNFa and IL-1b in chronically infected cells of to bind the HIV-1 DSE. AP-1 proteins cross dimerize with
CREB/ATF proteins (Hai and Curran, 1991; Chatton et al.,monocyte/macrophage lineage. TNFa and IL-1b activate
the Jun N-terminal kinase pathway (Brenner et al., 1989; 1994; Benbrook and Jones, 1990). Thus, the cooperativity
between TNFa and Ctx could be mediated by the hetero-Guan et al., 1996; Westwick et al., 1994) and have been
reported to also cooperate with activators of the cAMP/ dimerization of AP-1 proteins activated by TNFa and
CREB/ATF proteins activated by Ctx. Since the DSE can-PKA pathway to synergistically induce IL-2 receptor ex-
pression in a human NK-like cell line (Scholz and Altman, not bind CREB/ATF homodimers (Rabbi et al., 1997), co-
operativity would appear to require the binding of cross1989). Our functional studies demonstrated that Ctx co-
operates with TNFa and IL-1b to activate transcription family dimers of the AP-1 and CREB/ATF families to the
HIV-1 DSE.through AP-1 binding TRE sites. As for HIV-1 transcrip-
tion, we found that Ctx cooperates with TNFa through We also showed that the DSE can bind JunD and cFos
(Roebuck et al., 1996). Activation of PKC by phorbol esterthe TRE-like DSE sites situated in the 5*-untranslated
leader region of the LTR. increases the protein content of JunD and cFos in DSE
binding complexes (Roebuck et al., 1996). JunD activatesPerhaps the most unexpected finding of the study was
that TNFa and IL-1b cooperated differently with Ctx. the transcription of the human proenkephalin gene
through a PKA-dependent mechanism (Kobiershi et al.,TNFa and IL-1b have been shown to activate NF-kB in
U1 cells (Granowitz et al., 1995) and are thought to func- 1991). In addition, cfos gene expression is activated by
the PKA signaling pathway through a cAMP-responsivetion through the NF-kB binding sites in the HIV-1 en-
hancer to activate viral expression (Griffin et al., 1989). element (Hartig et al., 1991) and AP-1 binding sites can
mediate synergistic effects between protein kinase CIndeed, mutations of the NF-kB binding sites abrogates
TNFa and IL-1b transcriptional responses in U1 cells (PKC) and cAMP through the induction of cFos, a major
component of AP-1 complexes (Kontny et al., 1992; Serk-(Rabbi et al., 1997). Nevertheless, the cooperativity be-
tween Ctx and the cytokines did not require an intact kola and Hurme, 1993). We also have shown that the
HIV-1 DSE can be transactivated by cFos and JunD (Roe-HIV-1 enhancer, but rather LTR sequences downstream
of transcription in the 5*-untranslated leader region. In buck et al., 1993, 1996). Thus, AP-1 binding activity on the
HIV-1 DSE may be induced by the cAMP/PKA pathway asparticular, the cooperativity between Ctx and TNFa re-
quired the AP-1 binding DSE sites, whereas the coopera- well as the PKC pathway.
The multiple AP-1 binding sites, as well as other DNAtivity between Ctx and IL-1b were not dependent on the
DSE, since mutations of the DSE had little or no effect binding sites, within the 5*-untranslated leader region
may comprise a downstream enhancer element involvedon LTR activity induced by Ctx and IL-1b. However, the
cooperativity between Ctx and IL-1b was abrogated by in the activation of latent proviral expression. It was re-
cently shown that transcriptional processivity requires aa deletion of LTR sequences in the 5*-untranslated leader
region between /39 and /222. Inclusion of 5*-untrans- threshold level of activation domain synergy that exceeds
the level required for transcriptional initiation (Blair etlated leader sequences to /80, which contain the TAR
element, restored the cooperativity between Ctx and IL- al., 1996). Moreover, the degree to which transcriptional
processivity is enhanced depends on the quantity of acti-1b, but not between Ctx and TNFa, consistent with its
dependence on the HIV-1 DSE. Thus, different regions vation domains recruited to the transcription complex.
Because HIV-1 expression in the absence of Tat is asso-of the 5*-untranslated leader sequence mediate the co-
operativity between Ctx and the two cytokines. Coopera- ciated with incomplete transcripts, a second enhancer
within the viral LTR may provide the additional activationtivity with TNFa requires the DSE, whereas cooperativity
with IL-1b requires 5*-untranslated sequences near the domain synergy required to achieve threshold activation
of transcriptional processivity. Thus, the virus may haveTAR element. TNFa and IL-1b indeed mediated gene
expression differently in several other systems. For ex- acquired a second enhancer in the 5*-untranslated
leader as a means to ensure the synthesis of full-lengthample, TNFa and IL-1 differentially induce the IL-6 gene
(Ng et al., 1994). transcripts essential for viral replication.
In addition, because the HIV-1 provirus becomes pack-We recently showed that Ctx increased CREB binding
to the DSE (Rabbi et al., 1997), suggesting that the DSE aged into chromatin upon integration into the host ge-
nome, a functional enhancer element downstream ofmediates the Ctx response at least in part through its
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of HTLV type 1 and HIV type 1 in human T cell lines. AIDS Res. Hum.transcription could be involved in the activation of tran-
Retroviruses 12, 829–832.scription associated with changes in proviral chromatin
Cannon, P., Kim, S. H., Ulich, C., and Kim, S. (1994). Analysis of Tat
structure. It was shown recently that proviral latency is function in human immunodeficiency virus type 1-infected low-level-
associated with a positioned nucleosome that could in- expression cell lines U1 and ACH-2. J. Virol. 68, 1993–1997.
Chatton, B., Bocco, J. L., Goetz, J., Gaire, M., Lutz, Y., and Kedinger, C.terfer with the function of the downstream enhancer by
(1994). Jun and Fos heterodimerize with ATFa, a member of the ATF/preventing transcription factor binding (Brown et al.,
CREB family and modulate its transcriptional activity. Oncogene 9,1996; Verdin, 1991). This suppressive nucleosome struc-
375–385.
ture is rapidly disrupted in response to TNFa (Verdin et Chowdhury, I. H., Koyangi, Y., Horiuchi, S., Hazeki, O., Ui, M., Kitano, K.,
al., 1993). Histone acetylation has also been shown to Golde, D. E., Takada, K., and Yamamoto, N. (1993). cAMP stimulates
human immunodeficiency virus (HIV-1) from latently infected cells ofdisrupt the chromatin structure and activate the HIV-1
monocye-macrophage lineage: Synergism with TNFa. Virology 194,promoter (Van Lint et al., 1996). This is particularly intrigu-
345–349.ing since it has recently been shown that phosphorylated
De Cesare, D., Vallone, D., Caracciolo, A., Sassone-Corsi, P., Nerlov,
CREB is a target for a histone acetlylase protein called C., and Verde, P. (1995). Heterodimerization of cJun with ATF-2 and
the CREB-binding protein (p300/CBP) (Kwok et al., 1994; c-Fos is required for positive and negative regulation of the human
urokinase enhancer. Oncogene 11, 365–376.Ogryzko et al., 1996; Banniste and Kouzarides, 1996).
Finnegan, A., Roebuck, K. A., Nakai, B. E., Gu, D. S., Rabbi, M. F., Song,Thus, phospho-CREB binding to the /160 DSE, which
S., Landay, A. L. (1996). IL-10 cooperates with TNFa to activate HIV-is positioned immediately downstream of the positioned
1 from latently and acutely infected cells of monocyte/macrophage
nucleosome, could recruit CBP and its histone acetyl- lineage. J. Immunol. 156, 841–851.
transferase activity to the LTR to facilitate the disruption Gaynor, R. B. (1992). Cellular transcription factors involved in the regula-
tion of HIV-1 gene expression. AIDS 6, 347–353.of the suppressive chromatin structure. In agreement
Gonzalez, G. A., Menzel, P., Leonard, J., Fischer, W. H., and Montminy,with this notion, it was recently shown that point muta-
M. R. (1991). Characterization of motifs which are critical for activitytions of several downstream transcription factor binding
of the cyclic AMP-responsive transcription factor CREB. Mol. Cell.
sites, including the AP-1 binding DSE, functionally inacti- Biol. 11, 1306–1312.
vate the HIV-1 LTR when it is constrained in a chromatin Granowitz, E. V., Saget, B. M., Wang, M. Z., Dinarello, C. A., Skolnik,
P. R. (1995). Interleukin 1 induces HIV-1 expression in chronicallyconfiguration (Kharroubi and Martin, 1996).
infected U1 cells: blockade by interleukin 1 receptor antagonist andIt is clear from these and other studies that LTR se-
tumor necrosis factor binding protein type 1. Mol. Med. 1, 667–677.quences downstream of transcription in the 5*-untrans-
Griffin, G. E., Leung, K., Folks, T. M., Kunkel, S., and Nabel, G. J. (1989).
lated leader region contain versatile regulatory elements Activation of HIV gene expression during monocyte differentiation
critical in the induction of the HIV-1 provirus. Regulatory by induction of NF-kappa B. Nature 339, 70–73.
Guan, Z., Tetsuka, T., Baier, L. D., Morrison, A. R. (1996). Interleukin-elements like the DSE can mediate synergistic re-
1 beta activates c-jun NH2-terminal kinase subgroups of mitogen-sponses to multiple activation signals and may provide
activated protein kinases in mesangial cells. Am. J. Physiol. 270,the means to rapidly induce HIV-1 transcription during
F634–F641.
cell activation. Hai, T., and Curran, T. (1991). Cross-family dimerization of transcription
factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc.
Natl. Acad. Sci. USA 88, 3720–3724.ACKNOWLEDGMENTS
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